Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

NCT07008664 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT07008664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07008664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
Lead sponsor
University of Maryland, Baltimore
Phase
Observational
Overall status
Recruiting
Start date
March 31, 2025
Completion date
April 30, 2032
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers (hv), lung cancer, lung cancer screening, unhealthy volunteers